Effectiveness of early treatment of lopinavir–ritonavir in patients with severe COVID-19: a case series
Pan Luo, Jian-ling Zheng, Yi Liu, Lin Qiu, Xiu-lan Liu, Hui-ying Xue, Dong Liu and Juan Li
DOI: https://doi.org/10.7861/clinmed.2020-0348
Clin Med January 2021 Pan Luo
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
*joint first authors
Roles: responsible pharmacist
Jian-ling Zheng
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
*joint first authors
Roles: responsible pharmacist
Yi Liu
BTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: associate chief pharmacist
Lin Qiu
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
Xiu-lan Liu
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
Hui-ying Xue
ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Roles: responsible pharmacist
Dong Liu
CTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
†joint corresponding authors
Roles: chief pharmacist
Juan Li
CTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
†joint corresponding authors
Roles: chief pharmacist

Article Information
vol. 21 no. 1 e80-e83
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online January 21, 2021.
Article Versions
- Latest version (December 18, 2020 - 04:52).
- You are viewing the most recent version of this article.
Copyright & Usage:
© Royal College of Physicians 2021. All rights reserved.
Author Information
- Pan Luo, responsible pharmacistA,*,
- Jian-ling Zheng, responsible pharmacistA,*,
- Yi Liu, associate chief pharmacistB,
- Lin Qiu, responsible pharmacistA,
- Xiu-lan Liu, responsible pharmacistA,
- Hui-ying Xue, responsible pharmacistA,
- Dong Liu, chief pharmacistC,† and
- Juan Li, chief pharmacistC,†⇑
- ATongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- BTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- CTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- *joint first authors
- †joint corresponding authors
- Address for correspondence: Prof Juan Li, Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. E-mail: lijuan{at}tjh.tjmu.edu.cn
Article usage
Cited By...
Article Tools
Effectiveness of early treatment of lopinavir–ritonavir in patients with severe COVID-19: a case series
Pan Luo, Jian-ling Zheng, Yi Liu, Lin Qiu, Xiu-lan Liu, Hui-ying Xue, Dong Liu, Juan Li
Clinical Medicine Jan 2021, 21 (1) e80-e83; DOI: 10.7861/clinmed.2020-0348
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.